MedPath
FDA Approval

LOVAZA

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 4, 2011
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Rebel Distributors Corp

Rebel Distributors Corp

118802834

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LOVAZA

Product Details

NDC Product Code
21695-795
Application Number
NDA021654
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 24, 2009
Code: D87YGH4Z0QClass: ACTIBQuantity: 1 g in 1 1
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
ALPHA-TOCOPHEROLInactive
Code: H4N855PNZ1Class: IACT
GELATINInactive
Code: 2G86QN327LClass: IACT
© Copyright 2025. All Rights Reserved by MedPath